Ketanserin, a 5-HT2 receptor antagonist, reduces sleep apneas in rats

Research Communications in Biological Psychology and Psychiatry

Volumn 26, Issue 1-2, 2001, Pages 3-14

  Radulovacki, Miodrag ^a,c   Pavlovic, Sasa ^a   Rakic, Andrei ^a   Janelidze, Marika ^b   Shermulis, Lisa ^a   Carley, David W ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; MALE; MONITORING; NONHUMAN; NONREM SLEEP; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REM SLEEP; SLEEP; SLEEP APNEA SYNDROME; WAKEFULNESS;

EID: 0035790004     PISSN: 10870695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Benington, J., Kodali, S. and Heller, C. (1994). Scoring transitions to REM sleep in rats based on the EEG phenomena of pre-REM sleep: An improved analysis of sleep structure. Sleep 17: 28-36.
2. Borbely A.A., Trachsel, L. and Tobler, I. (1988). Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur. J. Pharmacol. 156: 275-278.
3. Breslin, E.H. (1981). Prevention and treatment of pulmonary complications in patients after surgery of the upper abdomen. Heart Lung 10: 511-519.
4. Carley, D.W. and Radulovacki, M. (1999). Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am. J. Respir. Crit. Care Med. 160: 1824-1829.
5. Carley, D.W., Trbovic, S. and Radulovacki, M. (1996). Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats. Sleep 19: 363-366.
6. Christon, J., Carley, D.W., Monti, D. and Radulovacki, M. (1996). Effects of inspired gas on sleep-related apneas in rats. J. Appl. Physiol. 80: 2102-2107.
7. Dugovic, C., Leysen, E.J., Janssen, P.F.M. and Wauquier, A. (1989). The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat. Pharmacol. Biochem. Behav. 34: 533-537.
8. 2 receptors in the modulation of the sleep/wakefulness states. Sleep Res. 1: 163-168.
9. King, E.D., O'Donnell, C.P., Smith, P.L. and Schwartz, A.R. (2000). A model of obstructive sleep apnea in normal humans. Role of the upper airway. Am. J. Respir. Crit. Care Med. 161: 1979-1984.
10. Kirov, R, and Moyanova, S. (1998). Age-dependent effect of ketanserin on the sleep-waking phases in rats. Int. J. Neuroscience 93: 257-264.
11. 2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol. Pharmacol. 21: 301-314.
12. Mendelson, W.B., Martin, J.V., Perlis, J.M., Giesen, H., Wagner, R. and Rapoport, S.I. (1988). Periodic cessation of respiratory effort during sleep in adult rats. Physiol. Behav. 43: 229-234.
13. Mickiels, M., Monbaliu, J., Meuldermans, W., Hendriks, R., Geerts, R., Woestenboroghs, R. and Heykants, J. (1988). Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Arzneimittelforschung 38: 775-784.
14. Monti, D., Carley, D.W. and Radulovacki, M. (1995). Adenosine analogs modulate the incidence of sleep apneas in rats. Pharmacol. Biochem. Behav. 51: 125-131.
15. Morin, D., Di Pasquale, E., Hilaire, G. and Monteau, R. (1994). Possible involvement of serotonin in obstructive apnea of the newborn. Biol. Neonate. 65: 176-181.
16. 2 antagonists on sleep in the rat. Pharmacol. Biochem. Behav. 44: 797-804.
17. Radulovacki, M., Trbovic, S.M. and Carley, D.W. (1996). Acute hypotension reduces sleep apneas in Zucker lean and Zucker obese rats. Sleep 19: 767-773.
18. 3-receptor antagonist GR 38032F suppresses sleep apneas in rats. Sleep 21: 131-136.
19. Sato T., Saito, H., Seto, K. and Takatsuji, H. (1990). Sleep apneas and cardiac arrhythmias in freely moving rats. Am. J. Physiol. 259: R282-R287.
20. 2C receptors. Neuropharmacology 33: 467-471.
21. 2 antagonist ritanserin on sleep-waking cycle in the rat. Pharmacol. Biochem. Behav. 41: 241-243.
22. Szarek, J.L. and Spurlock, B. (1997). Sensory nerve-mediated inhibitory responses in airways of F344 rats. Toxicology 122: 101-110.
23. Thomas, A.J., Austin, W., Friedman, L. and Strohl, K.P. (1992). A model of ventilatory instability induced in the unrestrained rat. J. Appl. Physiol. 73: 1530-1536.
24. Van de Graaff W.B. (1988). Thoracic influence on upper airway patency. J. Appl. Physiol. 65: 2124-2131.
25. Veasey, S.C., Fenik,P., Chachkes, J., Pack, A.I. and Hendricks, J.C. (2001). The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 24: 155-160.
26. Veasey, S. C., Panckeri, K.A., Hoffman, E.A., Pack, A.I. and Hendricks, J.C. (1996). The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 153: 766-786.
27. Wang, D., Post, M. and Cutz,E. (1999). Expression of serotonin receptor 2c in rat type II pneumocytes. Am. J. Respir. Cell Mol. Biol. 6:1175-1180.
28. Yoshioka, M., Goda, Y., Togashi, H., Matsumoto, M. and Saito, H. (1992). Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J. Pharmacol. Exp. Ther. 260: 917-924.